Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesOsteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
Osteoporosis International, 10/12/09
Breart G et al. – This study shows a greater association of VTE in osteoporotic compared to non-osteoporotic patients, but does not show any greater association in treated patients with strontium ranelate or alendronate compared to untreated osteoporotic patients.
Methods- Retrospective study
- Cohorts consisted of untreated osteoporotic women (N?=?11,546), osteoporotic women treated with alendronate (N?=?20,084), or strontium ranelate (N?=?2,408), and sample of non-osteoporotic women (N?=?115,009)
- Cohorts compared using Cox proportional hazards regression model
- Significantly increased relative risk for VTE in untreated osteoporotic women versus non-osteoporotic women (annual incidence 5.6 and 3.2 per 1,000 patient–years
- Results confirmed using adjusted models
- Annual incidences of VTE in osteoporotic patients treated with strontium ranelate and alendronate were 7.0 and 7.2 per 1,000 patient–years
- No significant difference between untreated and treated patients whatever the treatment
- Adjusted hazard ratios for treated versus untreated osteoporotic women 1.09 (95% CI, 0.60–2.01) for strontium ranelate and 0.92 (95% CI, 0.63–1.33) for alendronate
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteoporosis risk assessment and ethnicity
Journal of General Internal Medicine, 12/07/09
Use of bisphosphonates in the treatment of pediatric osteoporosis
International Journal of Clinical Rheumatology, 12/04/09
Vitamin K2 supplementation does not influence bone loss in early menopausal women: A randomised double-blind placebo-controlled trial
Osteoporosis International, 12/03/09
Sponsor
Article Search
Sponsor